EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2008 -6.70
September 30, 2008 -2.30
June 30, 2008 -2.50
March 31, 2008 -3.00
December 31, 2007 -2.70
September 30, 2007 -3.20
June 30, 2007 -3.80
March 31, 2007 -3.40
December 31, 2006 -3.90
September 30, 2006 -4.60
June 30, 2006 -8.40
March 31, 2006 -6.10
December 31, 2005 -5.60
September 30, 2005 -5.80
June 30, 2005 -9.20
March 31, 2005 -4.50
Date Value
December 31, 2004 -5.10
September 30, 2004 -3.90
June 30, 2004 -5.30
March 31, 2004 -4.80
December 31, 2003 -32.40
September 30, 2003 -34.20
June 30, 2003 -58.13
March 31, 2003 -50.30
December 31, 2002 -21.16
September 30, 2002 -71.76
June 30, 2002 -140.92
March 31, 2002 -161.08
December 31, 2001 -12.56
September 30, 2001 -7.647
June 30, 2001 -8.238
March 31, 2001 -6.746

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 2.268
Eli Lilly & Co. 7.939